Health-related quality of life impact of a triple combination of olmesartan medoxomil, amlodipine besylate and hydrochlorotiazide in subjects with hypertension

BACKGROUND: A post-hoc analysis was performed on the data from a 54 weeks phase III study (ClinicalTrials.gov identifier: NCT00923091) to measure changes in the health-related quality of life (HRQoL) of 2,690 patients aged ≥18 with moderate-to-severe hypertension who received one of six doses of olm...

Descripción completa

Detalles Bibliográficos
Autores principales: Marques da Silva, Pedro, Haag, Uwe, Guest, Julian F, Brazier, John E, Soro, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339651/
https://www.ncbi.nlm.nih.gov/pubmed/25879524
http://dx.doi.org/10.1186/s12955-015-0216-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339651/
https://www.ncbi.nlm.nih.gov/pubmed/25879524
http://dx.doi.org/10.1186/s12955-015-0216-6

Ejemplares similares